Insider · CIK 0001281933

BRATTON DOUGLAS K

Reports to the SEC for 4 companies · FORT WORTH, TX

sec.gov

Transactions

Companies

Filings

CIK

0001281933

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-12-02	AQSTAquestive Therapeutics, Inc.G Gift	10% Owner	GGift	−40K sh	—	—	199,841
2022-06-14	MIDWEST HOLDING INC.A Award	Director, 10% Owner	AAward	+2,674 sh	—	—	447,845
2021-11-11	MIDWEST HOLDING INC.A Award	Director, 10% Owner	AAward	+727 sh	—	—	445,171
2021-03-12	AQSTAquestive Therapeutics, Inc.J Other	10% Owner	JOther	−2.25M sh	—	—	0
2021-03-12	AQSTAquestive Therapeutics, Inc.J Other	10% Owner	JOther	+1.78M sh	—	—	1,948,578
2021-03-12	AQSTAquestive Therapeutics, Inc.J Other	10% Owner	JOther	−564K sh	—	—	3,468,747
2021-03-12	AQSTAquestive Therapeutics, Inc.J Other	10% Owner	JOther	−525K sh	—	—	1,688,639
2021-03-12	AQSTAquestive Therapeutics, Inc.J Other	10% Owner	JOther	−97.6K sh	—	—	2,657,943
2021-03-12	AQSTAquestive Therapeutics, Inc.J Other	10% Owner	JOther	−40.4K sh	—	—	47,051
2021-03-09	AQSTAquestive Therapeutics, Inc.G Gift	10% Owner	GGift	−62.5K sh	—	—	12,585
2021-02-12	DNLIDenali Therapeutics Inc.S Sale	10% Owner	SSale	−2.22M sh	$65.00	−$144M	9,984,836
2020-12-21	DNLIDenali Therapeutics Inc.J Other	10% Owner	JOther	−383K sh	—	—	0
2020-12-14	DNLIDenali Therapeutics Inc.S Sale	10% Owner	SSale	−876 sh	$81.13	−$71.1K	383,411
2020-12-14	DNLIDenali Therapeutics Inc.S Sale	10% Owner	SSale	−16.9K sh	$80.35	−$1.36M	384,287
2020-12-11	DNLIDenali Therapeutics Inc.S Sale	10% Owner	SSale	−46.8K sh	$80.05	−$3.75M	401,236
2020-08-12	DNLIDenali Therapeutics Inc.S Sale	10% Owner	SSale	−1.44M sh	$31.65	−$45.7M	12,201,634
2020-07-31	MIDWEST HOLDING INC.Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+50K sh	—	—	50,000
2020-06-30	DNLIDenali Therapeutics Inc.S Sale	10% Owner	SSale	−200 sh	$24.34	−$4,868	448,035
2020-06-30	DNLIDenali Therapeutics Inc.S Sale	10% Owner	SSale	−45.1K sh	$24.01	−$1.08M	448,235
2020-06-29	DNLIDenali Therapeutics Inc.S Sale	10% Owner	SSale	−61.8K sh	$23.84	−$1.47M	514,151
2020-06-29	DNLIDenali Therapeutics Inc.S Sale	10% Owner	SSale	−20.8K sh	$24.50	−$509K	493,380
2020-06-26	DNLIDenali Therapeutics Inc.S Sale	10% Owner	SSale	−13.6K sh	$24.67	−$336K	575,958
2020-06-26	DNLIDenali Therapeutics Inc.S Sale	10% Owner	SSale	−108K sh	$23.84	−$2.59M	589,562
2020-06-23	DNLIDenali Therapeutics Inc.S Sale	10% Owner	SSale	−16.8K sh	$25.69	−$431K	701,282
2020-06-23	DNLIDenali Therapeutics Inc.S Sale	10% Owner	SSale	−3,247 sh	$26.19	−$85K	698,035
2020-06-22	DNLIDenali Therapeutics Inc.S Sale	10% Owner	SSale	−65.4K sh	$24.66	−$1.61M	742,742
2020-06-22	DNLIDenali Therapeutics Inc.S Sale	10% Owner	SSale	−24.7K sh	$25.12	−$620K	718,059
2020-06-19	DNLIDenali Therapeutics Inc.S Sale	10% Owner	SSale	−62.4K sh	$25.00	−$1.56M	808,115
2020-06-19	DNLIDenali Therapeutics Inc.S Sale	10% Owner	SSale	−82.5K sh	$24.20	−$2M	870,554
2020-06-16	AQSTAquestive Therapeutics, Inc. · Stock Option (Right to Purchase)A Award	10% Owner	AAward	+14K sh	—	—	14,000
2020-06-05	DNLIDenali Therapeutics Inc.S Sale	10% Owner	SSale	−1.92M sh	$25.75	−$49.5M	13,644,881
2020-02-26	DNLIDenali Therapeutics Inc.S Sale	10% Owner	SSale	−3.89M sh	$20.25	−$78.9M	15,567,736
2019-06-13	AQSTAquestive Therapeutics, Inc. · Stock Option (Right to Purchase)A Award	10% Owner	AAward	+13.4K sh	—	—	13,350
2019-03-25	DNLIDenali Therapeutics Inc.J Other	10% Owner	JOther	−159K sh	—	—	953,035
2018-07-24	AQSTAquestive Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+165K sh	$15.00	+$2.48M	165,000
2018-07-24	AQSTAquestive Therapeutics, Inc. · Stock Option (Right to Purchase)A Award	10% Owner	AAward	+26.7K sh	—	—	26,700
2017-12-12	DNLIDenali Therapeutics Inc. · Series A-1 Convertible Preferred StockC Conversion	10% Owner	CConversion	−14.5M sh	—	—	0
2017-12-12	DNLIDenali Therapeutics Inc.C Conversion	10% Owner	CConversion	+14.5M sh	—	—	14,812,499
2017-12-12	DNLIDenali Therapeutics Inc.C Conversion	10% Owner	CConversion	+2.5M sh	—	—	17,312,499
2017-12-12	DNLIDenali Therapeutics Inc.C Conversion	10% Owner	CConversion	+1.88M sh	—	—	19,187,499
2017-12-12	DNLIDenali Therapeutics Inc.C Conversion	10% Owner	CConversion	+744K sh	—	—	743,599
2017-12-12	DNLIDenali Therapeutics Inc.C Conversion	10% Owner	CConversion	+128K sh	—	—	871,799
2017-12-12	DNLIDenali Therapeutics Inc.C Conversion	10% Owner	CConversion	+240K sh	—	—	1,111,799
2017-12-12	DNLIDenali Therapeutics Inc.P Purchase	10% Owner	PPurchase	+275K sh	$18.00	+$4.95M	19,462,499
2017-12-12	DNLIDenali Therapeutics Inc. · Series A-2 Convertible Preferred StockC Conversion	10% Owner	CConversion	−2.5M sh	—	—	0
2017-12-12	DNLIDenali Therapeutics Inc. · Series B-1 Convertible Preferred StockC Conversion	10% Owner	CConversion	−1.88M sh	—	—	0
2017-12-12	DNLIDenali Therapeutics Inc. · Series A-1 Convertible Preferred StockC Conversion	10% Owner	CConversion	−744K sh	—	—	0
2017-12-12	DNLIDenali Therapeutics Inc. · Series A-2 Convertible Preferred StockC Conversion	10% Owner	CConversion	−128K sh	—	—	0
2017-12-12	DNLIDenali Therapeutics Inc. · Series B-1 Convertible Preferred StockC Conversion	10% Owner	CConversion	−240K sh	—	—	0
2017-07-13	Juno Therapeutics, Inc.S Sale	10% Owner	SSale	−8M sh	$27.00	−$216M	9,166,130

Recent filings

Accepted (ET)
Dec 44
BRATTON DOUGLAS K0000950170-24-133320
SEC(opens sec.gov)
Jun 164
Crestline Management, LP0000899243-22-022799
SEC(opens sec.gov)
Nov 154
Crestline Management, LP0000899243-21-044580
SEC(opens sec.gov)
Mar 164
BRATTON DOUGLAS K0001214659-21-003203
SEC(opens sec.gov)
Feb 174
BRATTON DOUGLAS K0000899243-21-007016
SEC(opens sec.gov)
Dec 234
Bratton Capital Inc.0000899243-20-035043
SEC(opens sec.gov)
Dec 154
BRATTON DOUGLAS K0000899243-20-033903
SEC(opens sec.gov)
Aug 144
BRATTON DOUGLAS K0000899243-20-022430
SEC(opens sec.gov)
Aug 44
BRATTON DOUGLAS K0000899243-20-021314
SEC(opens sec.gov)
Jun 304
BRATTON DOUGLAS K0000899243-20-018024
SEC(opens sec.gov)

Companies

Address

201 MAIN STREET, SUITE 1900

FORT WORTH, TX, 76102